What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Vincent A. Miller focuses on Internal medicine, Lung cancer, Oncology, Cancer research and Erlotinib.
His biological study spans a wide range of topics, including Endocrinology and Surgery.
His studies in Lung cancer integrate themes in fields like Cancer, Adenocarcinoma, Carboplatin, Gastroenterology and EGFR inhibitors.
His research integrates issues of Hazard ratio, KRAS and Carcinoma, Pathology in his study of Oncology.
His work carried out in the field of Cancer research brings together such families of science as Bioinformatics, Mutation, Tyrosine kinase, Anaplastic lymphoma kinase and Kinase.
His Erlotinib research includes themes of T790M, Pharmacology and Gefitinib.
His most cited work include:
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib (3644 citations)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3017 citations)
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain (2867 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Cancer and Lung cancer.
While the research belongs to areas of Internal medicine, Vincent A. Miller spends his time largely on the problem of Bioinformatics, intersecting his research to questions surrounding Colorectal cancer.
His study looks at the relationship between Oncology and topics such as KRAS, which overlap with CDKN2A.
His work in Cancer research covers topics such as Gene which are related to areas like Ligation.
Vincent A. Miller interconnects Phases of clinical research, Carcinoma, Pharmacology and Docetaxel in the investigation of issues within Lung cancer.
His Erlotinib research is multidisciplinary, relying on both T790M and Gefitinib.
He most often published in these fields:
- Internal medicine (44.30%)
- Oncology (39.07%)
- Cancer research (37.41%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (37.41%)
- Internal medicine (44.30%)
- Oncology (39.07%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Internal medicine, Oncology, Genomic profiling and Cancer.
His Cancer research study integrates concerns from other disciplines, such as Mutation, Gene, Microsatellite instability, Lung cancer and Immunotherapy.
His Internal medicine research is multidisciplinary, incorporating perspectives in Precision medicine and MEDLINE.
The Oncology study combines topics in areas such as KRAS, Colorectal cancer, Clinical trial and CDKN2A.
His Genomic profiling research incorporates elements of Liquid biopsy, Malignancy, Pathology and Computational biology.
His work deals with themes such as Biomarker, Blockade, PI3K/AKT/mTOR pathway and Allele frequency, which intersect with Cancer.
Between 2017 and 2021, his most popular works were:
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. (429 citations)
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study (144 citations)
- Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. (130 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Cancer research, Internal medicine, Oncology, Cancer and Gene.
The concepts of his Cancer research study are interwoven with issues in Mutation, MEK inhibitor, Carcinoma, Lung cancer and Kinase.
Vincent A. Miller works mostly in the field of Lung cancer, limiting it down to concerns involving Targeted therapy and, occasionally, RNA.
His Internal medicine study frequently draws connections between adjacent fields such as Microsatellite instability.
His Oncology research includes elements of Prospective cohort study, Cohort and Gene expression profiling.
He has researched Cancer in several fields, including Concordance and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
